It is estimated that over 7 million people are living with Alzheimer's Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe's ageing population. In this series of articles, Euractiv will explore the state …
Greg Rossi discusses the imperative to address cancer in Europe with early detection, precision medicine and equitable access. Stressing the need for urgent action to make cancer a manageable condition, highlighting disparities and the importance of innovation.
There are millions of people in Europe who are affected by diabetes and related conditions. This number is only expected to grow in the coming years. However, with technological advancements, it is possible that those affected by the disease are able …
Innovation in science is advancing cancer care through early detection and treatment, bringing significant economic benefits to healthcare systems. Future incentives for innovation, particularly early detection and treatment approaches, must be recognised so that patients can benefit from this progress.
Through policy action we can all play a part in turning the tide against the growing global health concern and burden of Alzheimer’s disease.
While the German healthcare system is at Europe's forefront in terms of making drugs available for the treatment of metastatic breast cancer, problems still arise as some important drugs have been withdrawn from the market.
